These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 13839129)

  • 1. The antithrombin titer in pancreatic disease.
    TRACHTMAN B; MATZNER MJ
    Am J Gastroenterol; 1960 Sep; 34():248-51. PubMed ID: 13839129
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma antithrombin patterns in disturbances of the pancreas.
    INNERFIELD I; ANGRIST A; BENJAMIN JW
    Gastroenterology; 1951 Dec; 19(4):843-54. PubMed ID: 14897078
    [No Abstract]   [Full Text] [Related]  

  • 3. The antithrombin titer in cystic fibrosis of the pancreas; a preliminary report.
    INNERFIELD I; ANGRIST A; BENJAMIN JW
    J Pediatr; 1951 Sep; 39(3):287-97. PubMed ID: 14881019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Substitution of antithrombin III by synthetic thrombin inhibitors].
    Hauptmann J; Brüggener E; Müller H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):550-5. PubMed ID: 6083925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some new data on antithrombin V].
    VERMYLEN C; VERSTRAETE M
    Belg Tijdschr Geneesk; 1961 Aug; 17():825-34. PubMed ID: 13780944
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin.
    Machovich R; Blaskó G; Borsodi A
    Thromb Haemost; 1976 Dec; 36(3):503-8. PubMed ID: 65798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of heparin-like antithrombin in blood diseases with special reference to leukemia].
    GAERTNER H; SZIRMAI E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1959; 76():116-25. PubMed ID: 13825878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of antithrombin determination in examination of diseases of the biliary tract, the liver, and the pancreas].
    ZURN H
    Z Arztl Fortbild (Jena); 1956 Sep; 50(17):727-9. PubMed ID: 13393041
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation of antithrombin globulin from human blood plasma.
    SHINOWARA GY; BUCKLEY DJ
    Thromb Diath Haemorrh; 1959 Dec; 4():17-30. PubMed ID: 14446029
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of in vivo and in vitro inhibition of thrombin by plasma inhibitors.
    Vogel CN; Kingdon HS; Lundblad RL
    J Lab Clin Med; 1979 Apr; 93(4):661-73. PubMed ID: 429864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlative study of the external pancreatic secretion, the plasma antithrombin titer, the blood amylase concentration, and the serum mucoprotein level in patients with and without pancreatic disease.
    DREILING DA; GREENSPAN EM; SANDERS M
    Gastroenterology; 1954 Dec; 27(6):755-65. PubMed ID: 13232158
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromatography of thrombin and antithrombin III on biospecific silochromes].
    Lohins'ka ZV; Oryshchenko NV; Vus MM; Maherovskyĭ IuV; Haĭda HZ; Haĭda AV
    Ukr Biokhim Zh (1978); 1998; 70(3):63-8. PubMed ID: 9848182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis.
    Boneu B; Sie P; Caranobe C; Cassigneul J; Pascal J
    Thromb Haemost; 1982 Feb; 47(1):78. PubMed ID: 7071809
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation of anhydro-thrombin and its interaction with plasma antithrombin III.
    Tomono T; Sawada E
    Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):969-79. PubMed ID: 3766081
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.